Drug or treatment

Mirvetuximab clinical trials

• 8Clinical trials
• 1New in 30 days
• 32Countries

Newest trials

All recruiting trials (8)

• Real-world use of mirvetuximab soravtansine in FRα-positive platinum-resistant ovarian, fallopian tube, and peritoneal cancer

  This study tests how mirvetuximab soravtansine works in real-world adults with FRα-positive platinum-resistant ovarian, fallopian tube, or peritoneal cancer.

  Recruiting AbbVie · Vienna · NCT07896421

• AZD5335 versus mirvetuximab or chemotherapy for FRα-high and FRα-low platinum-resistant ovarian, fallopian tube, or peritoneal cancer

  This will test whether AZD5335 works better than mirvetuximab for FRα-high tumors or better than single-agent chemotherapy for FRα-low tumors in women with high-grade, platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer.

  Recruiting at 95 sites Phase 3 AstraZeneca · Birmingham, Alabama and 298 other locations · NCT07218809

• Sofetabart Mipitecan (LY4170156) versus standard chemotherapy for platinum-resistant and platinum-sensitive high-grade ovarian, fallopian tube, and primary peritoneal cancer

  This trial tests whether the targeted drug Sofetabart Mipitecan can better shrink tumors or delay progression than standard chemotherapies for people with platinum-resistant or platinum-sensitive high-grade ovarian, fallopian tube, or primary peritoneal cancer.

  Recruiting at 212 sites Phase 3 Eli Lilly and Company · Birmingham, Alabama and 263 other locations · NCT07213804

• Mirvetuximab soravtansine combined with bevacizumab or carboplatin for FRα‑positive ovarian cancer

  This Phase 2 trial tests whether giving intravenous mirvetuximab soravtansine with bevacizumab or carboplatin is safe and can change disease activity in adults with folate receptor alpha (FRα)–positive high‑grade ovarian, fallopian tube, or primary peritoneal cancer.

  Recruiting at 85 sites Phase 2 AbbVie · La Jolla, California and 85 other locations · NCT07059845

• Combining carboplatin with mirvetuximab soravtansine before surgery for FRα-positive advanced serous ovarian, fallopian tube, or primary peritoneal cancer

  This will test whether giving mirvetuximab soravtansine with carboplatin before surgery helps people with newly diagnosed FRα-positive advanced-stage serous ovarian, fallopian tube, or primary peritoneal cancer.

  Recruiting at 71 sites Phase 2 AbbVie · Birmingham, Alabama and 72 other locations · NCT06890338

• Mirvetuximab soravtansine for platinum-resistant high-grade ovarian, fallopian tube, and primary peritoneal cancer with high folate receptor-alpha

  This trial tests whether intravenous mirvetuximab soravtansine helps people with platinum-resistant high-grade ovarian, fallopian tube, or primary peritoneal cancer whose tumors have high folate receptor-alpha.

  Recruiting at 52 sites Phase 2 AbbVie · Sarasota, Florida and 51 other locations · NCT06682988

• Carboplatin and Mirvetuximab for Advanced Ovarian Cancer Treatment

  This study is testing if a combination of carboplatin and mirvetuximab can help women with advanced ovarian cancer do better after their initial chemotherapy before surgery.

  Recruiting at 9 sites Phase 2 University of Alabama at Birmingham · Birmingham, Alabama and 8 other locations · NCT04606914

• Evaluating a new treatment for women with specific types of endometrial cancer

  This study is testing a new treatment called mirvetuximab soravtansine to see if it can help women with certain types of endometrial cancer feel better and live longer.

  Recruiting Phase 2 Yale University · New Haven, Connecticut · NCT03832361

Quick answers

How many clinical trials of Mirvetuximab are recruiting right now?

8, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 32 countries. The most sites are in United States (7 trials), Australia (4 trials), Belgium (4 trials), France (4 trials), South Korea (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →